Immunoglobulins, specific

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

Hyperimmunoglobulin; Pseudomonas immunoglobulin; Rubella immunoglobulin; TBE immunoglobulin

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Immunoglobulins, which contain antibodies against certain diseases in particularly high concentrations. See tab.

TablesThis section has been translated automatically.

Overview of the most important specific immunoglobulins

Immunoglobulin

Indication

Dosage

Finished preparation

hepatitis B

Hepatitis B prophylaxis in case of increased risk of infection (dialysis, needlestick injuries)

Simultaneous prophylaxis (simultaneously with the 1st dose of HBV vaccine): 0.06 ml/kg bw i.m. For newborns: total dose of 1 ml i.m.

Hepatitis B immunoglobulin Behring

In case of exposure/suspicion (no simultaneous prophylaxis with HBV vaccine): at least 0.06 ml/kg bw i.m., repeat with same dose after 4 weeks.

In case of massive exposure (e.g. after transfusion of HBV-infected blood or blood components): at least 0.12 ml/kg bw i.m.

Continuous prophylaxis 0.06 ml/kg bw at intervals of 3 months

CMV

Prophylaxis of CMV infections after transplantation or in HIV patients with < 50 CD4 cells/μl

50-100 IU/kg bw i.v. every 14 days, according to clinical course

Cytotect

VZV

Prophylaxis of varicella in immunocompromised patients,

1 ml/kg bw i.v. within 3 days after exposure

e.g. Varitect

Herpes zoster in immunocompromised patients

2 ml/kg bw i.v.

Authors

Last updated on: 29.10.2020